# Hyderabad doctor secures affordable rare disease drug for seven children

2026-11-19T05:51:42+00:00 | Health & Science | Indian Opinion Desk

Corroboration: 2 independent outlets
Outlets counted: telanganatoday.com, thehindu.com

Seven children with the rare genetic disorder Allan-Herndon-Dudley syndrome (AHDS) are to receive a year's supply of Tiratricol free of cost on 30 November. The initiative is led by Hyderabad-based paediatrician Dr Sivaranjani Santosh and Access to Medicines India, with the medicine compounded by Transvaal Pharmacy in the Netherlands through the Pharmaceutical Accountability Foundation (PAF). Commercial versions of the drug cost Rs 4.68 crore to Rs 9 crore annually per child, the compounded formulation costs about Rs 2.5 lakh. PAF said the total cost for the seven children is €14,200, of which Dr Sivaranjani raised Rs 6.09 lakh in India and PAF raised the remaining €8,600 in the Netherlands. The families have secured import permits for one year, the medicine will arrive in two batches due to its six-month shelf life. Dr Sivaranjani said she plans to approach the Union government to encourage domestic compounding of the medicine, calling reliance on imports unsustainable.

## Indian Opinion Analysis

Telangana Today led with the cost reduction, mentioning that commercial variants run Rs 4.68 crore to Rs 9 crore a year and the compounded version costs Rs 2.5 lakh. The Hindu led with the same figures but also reported that the children will receive the medicine free of cost, added detail on the fundraising in India and the Netherlands, and included the doctor's direct quote urging domestic production. Both outlets attribute the initiative to Dr Sivaranjani Santosh and the same partner organisations, their coverage is largely uniform straight reporting with the same facts. The difference is that The Hindu gives deeper background on the sourcing, the social media campaign, and the two-batch import plan based on the six-month shelf life, while Telangana Today is more condensed.

## Coverage

Coverage: 2 sources, 2 neutral
- telanganatoday.com (neutral report) <https://telanganatoday.com/hyderabad-doctor-secures-affordable-rare-disease-drug-for-seven-children-with-ahds>
  Straight reporting of the cost reduction and handover event
- thehindu.com (neutral report) <https://www.thehindu.com/news/cities/Hyderabad/hyderabad-doctor-brings-down-rare-disease-drug-cost-by-65-lakh-seven-children-to-get-free-treatment/article71718621.ece>
  Straight reporting with deeper background on fundraising and sourcing

This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry.

Tags: Allan-Herndon-Dudley syndrome, Dr Sivaranjani Santosh
Canonical: https://indianopinion.org/hyderabad-doctor-secures-affordable-rare-disease-drug-for-seven-children/
License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources.
Cite: https://indianopinion.org/hyderabad-doctor-secures-affordable-rare-disease-drug-for-seven-children/#story-in-brief

Review state: not offered to search indexes, readable and citable here.

How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/
